Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Alzheimer's Disease

  Free Subscription

Articles published in Biol Psychiatry

Retrieve available abstracts of 6 articles:
HTML format
Text format

Single Articles

    May 2017
  1. GOIRAN T, Duplan E, Chami M, Bourgeois A, et al
    beta-Amyloid Precursor Protein Intracellular Domain Controls Mitochondrial Function by Modulating Phosphatase and Tensin Homolog-Induced Kinase 1 Transcription in Cells and in Alzheimer Mice Models.
    Biol Psychiatry. 2017 May 3. pii: S0006-3223(17)31515.
    PubMed     Text format     Abstract available

    March 2017
  2. SHEN Y, Wang H, Sun Q, Yao H, et al
    Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
    Biol Psychiatry. 2017 Mar 27. pii: S0006-3223(17)30098.
    PubMed     Text format     Abstract available

  3. ZHAO N, Liu CC, Qiao W, Bu G, et al
    Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease.
    Biol Psychiatry. 2017 Mar 14. pii: S0006-3223(17)31358.
    PubMed     Text format     Abstract available

    January 2017
  4. BRANCA C, Oddo S
    Paving the Way for New Clinical Trials for Alzheimer's Disease.
    Biol Psychiatry. 2017;81:88-89.
    PubMed     Text format    

    March 2016
  5. FOLEY SF, Tansey KE, Caseras X, Lancaster T, et al
    Multimodal Brain Imaging Reveals Structural Differences in Alzheimer's Disease Polygenic Risk Carriers: A Study in Healthy Young Adults.
    Biol Psychiatry. 2016 Mar 16. pii: S0006-3223(16)31114.
    PubMed     Text format     Abstract available

    April 2015
  6. MANDAL PK, Saharan S, Tripathi M, Murari G, et al
    Brain Glutathione Levels - A Novel Biomarker for Mild Cognitive Impairment and Alzheimer's Disease.
    Biol Psychiatry. 2015 Apr 14. pii: S0006-3223(15)00312.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.